Medicare expands hearing loss treatment access for seniors
H.R. 1921 — Hearing Device Coverage Clarification Act · Filed by Michelle Fischbach (R-MN) · 5 cosponsors · Introduced Mar 6, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs Medicare to clarify that fully implanted active middle ear hearing devices (surgically placed devices that amplify sound directly to the inner ear) are prosthetics covered by Medicare, not hearing aids excluded from coverage. Currently, Medicare excludes hearing aids from coverage; this bill ensures that a different category of device—one surgically implanted rather than worn—is treated as a prosthetic and therefore covered.
Why we flagged it
The bill is a narrow, technical clarification of Medicare coverage policy for a specific medical device category. It does not create new law but directs an agency to issue guidance distinguishing implanted devices from excluded hearing aids.
What the text implies
- The clarification may trigger coverage determinations for existing beneficiaries who were previously denied implanted middle ear devices; CMS may face retroactive coverage requests.
- Device manufacturers (Cochlear, MED-EL, Oticon Medical) may see increased demand if the clarification removes prior authorization barriers or cost-sharing uncertainty.
The full analysis lists 3 implications of this text.
Who stands to gain
manufacturers of implanted middle ear devices (Cochlear Limited, MED-EL, Oticon Medical); surgical centers and otolaryngologists performing implantation procedures; Medicare beneficiaries with severe-to-profound hearing loss